Structures by: Baouid A.
Total: 32
1-(Cyclohex-1-en-1-yl)-3-[(1-phenyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C22H21N5O
IUCrData (2017) 2, 6 x170907
a=8.5878(8)Å b=9.0603(8)Å c=12.8566(12)Å
α=85.076(7)° β=82.558(7)° γ=70.917(8)°
(<i>E</i>)-2-Phenyl-4-styryl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepine hemihydrate
C23H20N2,0.5(H2O1)
IUCrData (2017) 2, 7 x171070
a=22.1001(8)Å b=6.7624(2)Å c=24.5714(7)Å
α=90° β=104.835(3)° γ=90°
(4<i>S</i>,5<i>R</i>)-3-(4-Chlorophenyl)-5-(4-methoxyphenyl)-4-methyl-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H21ClN2O
IUCrData (2016) 1, 6 x161022
a=19.564(16)Å b=9.127(8)Å c=11.001(10)Å
α=90.00° β=94.88(4)° γ=90.00°
C33H38N4O2
C33H38N4O2
New Journal of Chemistry (2001)
a=22.9235(7)Å b=9.9309(5)Å c=12.8363(7)Å
α=90.000(10)° β=101.078(3)° γ=90.000(10)°
C33H38N4O2
C33H38N4O2
New Journal of Chemistry (2001) 25, 12 1479-1481
a=22.9235(7)Å b=9.9309(5)Å c=12.8363(7)Å
α=90.000(10)° β=101.078(3)° γ=90.000(10)°
C31H30Cl2N6O4
C31H30Cl2N6O4
New Journal of Chemistry (2003) 27, 11 1644
a=16.749(3)Å b=23.587(5)Å c=17.758(4)Å
α=90.00° β=116.76(3)° γ=90.00°
Ethyl 2-(1<i>H</i>-benzimidazol-2-yl)-2-[2-(4-nitrophenyl)hydrazinylidene]acetate
C17H15N5O4
Acta Crystallographica Section E (2015) 71, 4 o236-o237
a=12.877(5)Å b=5.874(5)Å c=21.988(5)Å
α=90.000(5)° β=99.060(5)° γ=90.000(5)°
C26H22Cl2N4O2
C26H22Cl2N4O2
Acta Crystallographica Section E (2003) 59, 11 o1774-o1776
a=13.1829(5)Å b=12.3225(5)Å c=15.2605(5)Å
α=90.0° β=106.8610(10)° γ=90.0°
1-(3-Chloro-4-tolyl)-5-méthylthio-3a-phényl-3a,11-dihydro-4H-[1,2,4] oxadiazolo[5,4-d][1,5]benzodiazépine
C24H20Cl1N3O1S1
Acta Crystallographica Section E (2002) 58, 5 o548-o550
a=8.6890(4)Å b=18.8253(9)Å c=13.3728(7)Å
α=90.0° β=103.470(3)° γ=90.0°
Ethyl 3-(4-chlorophényl)-3a-méthyl- 5-phényl-3,3a,4,11-tétrahydro-3H-[1,2,4] triazolo [4,3-a] [1,5] benzodiazépine
C26H23ClN4O2
Acta Crystallographica Section C (1995) 51, 5 961-963
a=10.207(8)Å b=26.978(12)Å c=8.744(6)Å
α=90.00° β=106.96(3)° γ=90.00°
?
C27H25ClN4O2
Acta Crystallographica Section C (1998) 54, 4 519-521
a=12.9850(10)Å b=14.036(2)Å c=13.314(3)Å
α=90.0(2)° β=102.7(3)° γ=90.0(3)°
?
C26H23N5O4
Acta Crystallographica Section C (1998) 54, 4 519-521
a=22.711(6)Å b=15.498(5)Å c=14.642(4)Å
α=90.00(2)° β=117.97(2)° γ=90.00(2)°
2α ,3α ,6α ,7α-diépoxyhimachalane
C15H24O2
Acta Crystallographica Section C (1996) 52, 10 2504-2507
a=8.537(2)Å b=8.221(2)Å c=10.364(2)Å
α=90.00° β=104.31(2)° γ=90.00°
1-mésityl-3a-méthyl-5-phényl-3,3a,4,11-tétrahydro-3H-[1,2,4] oxadiazolo [4,5-a] [1,5] benzodiazépine
C26H25N3O
Acta Crystallographica Section C (1995) 51, 9 1898-1900
a=8.521(3)Å b=15.367(6)Å c=16.892(6)Å
α=90.00° β=90.00° γ=90.00°
1,7-diéthoxycarbonyl-3a-méthyl-4a-phényl- 3,5-diparanitrophényl-3a,4,4a,5-tétrahydro-3H-bis[1,2,4] triazolo[4,3-a:3,4'-d][1,5]benzodiazépine
C36H32N8O8,C1H1Cl3
Acta Crystallographica Section C (1995) 51, 7 1352-1355
a=12.044(7)Å b=12.461(7)Å c=13.730(8)Å
α=104.33(3)° β=94.47(3)° γ=101.00(3)°
?
C23H18ClN3O
Acta Crystallographica Section C (1996) 52, 9 2281-2282
a=19.685(1)Å b=11.023(2)Å c=8.881(3)Å
α=90.0(2)° β=98.4(3)° γ=90.0(3)°
C23H24N4O3
C23H24N4O3
Acta Crystallographica Section C (1999) 55, 2 IUC9900010
a=9.5570(10)Å b=16.1400(10)Å c=13.6880(10)Å
α=90.0000(10)° β=100.9780(10)° γ=90.0000(10)°
C23H26ClN4O3
C23H26ClN4O3
Acta Crystallographica Section C (1999) 55, 2 IUC9900010
a=9.9420(10)Å b=16.1840(10)Å c=13.7870(10)Å
α=90.0000(10)° β=107.6400(10)° γ=90.0000(10)°
C26H24N4O
C26H24N4O
Acta Crystallographica Section C (1999) 55, 9 1528-1530
a=8.8118(4)Å b=11.6060(6)Å c=12.1748(7)Å
α=115.234(2)° β=107.660(3)° γ=95.643(3)°
Rac-Ethyl (8a<i>R</i>,9a<i>S</i>)-8a-methyl-8-(4-nitrophenyl)-9a,10- diphenyl-12-(p-tolyl)-9,9a-dihydro-8a<i>H</i>-di-1,2,4- triazolo[4,3-a:3',4'-d][1,5]benzodiazepine-6-carboxylate
C40H35N7O4
Acta Crystallographica Section E (2007) 63, 7 o3301-o3302
a=9.4951(6)Å b=21.4360(10)Å c=18.8850(10)Å
α=90.00° β=114.011(5)° γ=90.00°
Rac-Ethyl 7-(4-chlorophenyl)-3a-methyl-3-(4-nitrophenyl)- 4a,5-diphenyl-3a,4a,8,13-tetrahydro-4H- bis[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine-1-carboxylate
C39H32ClN7O4
Acta Crystallographica Section E (2007) 63, 4 o1544-o1545
a=17.3927(9)Å b=9.2018(5)Å c=22.8460(10)Å
α=90.00° β=107.102(5)° γ=90.00°
Ethyl 5-[2-(2-aminophenylimino)-2-phenylethylidene]- 4-(4-chlorophenyl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate
C25H21ClN4O2S
Acta Crystallographica Section C (2002) 58, 9 o585-o588
a=9.98260(10)Å b=9.5040(2)Å c=25.0790(10)Å
α=90° β=90.667(5)° γ=90°
Ethyl 5-{2-[2-(methylamino)phenylimino]-2-phenylethylidene}- 4-(4-nitrophenyl)-4,5-dihydro-1,3,4-thiadiazole-2-carboxylate
C26H23N5O4S
Acta Crystallographica Section C (2002) 58, 9 o585-o588
a=9.7619(2)Å b=10.7465(3)Å c=12.1924(2)Å
α=87.137(2)° β=83.151(2)° γ=75.4690(10)°
C33H38N4O2
C33H38N4O2
Acta Crystallographica Section C (2000) 56, 1 e25-e26
a=22.9235(7)Å b=9.9309(5)Å c=12.8363(7)Å
α=90.000(10)° β=101.078(3)° γ=90.000(10)°
C26H23N5O4S
C26H23N5O4S
Acta Crystallographica Section C (2000) 56, 10 e457-e458
a=18.4896(3)Å b=14.4128(5)Å c=18.6685(6)Å
α=90.000(10)° β=97.977(3)° γ=90.000(10)°
C23H25N3O2
C23H25N3O2
Acta Crystallographica Section C (2000) 56, 10 e459-e460
a=14.4861(5)Å b=16.8720(10)Å c=17.9161(6)Å
α=90.000(10)° β=152.698(2)° γ=90.000(10)°
Diethyl 1,4-bis(4-nitrophenyl)-1,4-dihydro-1,2,4,5-tetrazine-3,6-dicarboxylate
C20H18N6O8
Acta Crystallographica Section E (2010) 66, 2 o430
a=20.739(4)Å b=7.487(2)Å c=14.587(3)Å
α=90.00° β=104.00(2)° γ=90.00°
4-Phenyl-1-(prop-2-yn-1-yl)-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C18H14N2O
Acta Crystallographica Section E (2011) 67, 8 o2075-o2076
a=8.2574(14)Å b=18.961(3)Å c=9.0914(15)Å
α=90.00° β=102.962(4)° γ=90.00°
Ethyl 5,5-dichloro-3-(4-chlorophenyl)-3a-methyl-4a-phenyl-3a,4,4a,5- tetrahydro-3<i>H</i>- aziridino[2,1-<i>d</i>][1,2,4]triazolo[4,3-<i>a</i>][1,5]benzodiazepine- 1-carboxylate
C27H23Cl3N4O2
Acta Crystallographica Section E (2011) 67, 5 o1211
a=9.679(3)Å b=11.256(3)Å c=12.661(2)Å
α=79.09(2)° β=76.46(2)° γ=73.04(2)°
(<i>E</i>)-3-[(Dimethylamino)methylidene]-4-phenyl-1-(prop-2-ynyl)-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C21H19N3O
Acta Crystallographica Section E (2014) 70, 1 o32
a=12.8122(10)Å b=13.9317(12)Å c=19.7795(14)Å
α=90.00° β=94.647(3)° γ=90.00°
(<i>E</i>)-3-[(Dimethylamino)methylidene]-4-phenyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C18H17N3O
Acta Crystallographica Section E (2014) 70, 2 o126
a=11.281(2)Å b=14.005(4)Å c=20.124(3)Å
α=90.00° β=95.970(10)° γ=90.00°
Ethyl 2-(2-methyl-1<i>H</i>-benzimidazol-1-yl)-2-[2-(4- nitrophenyl)hydrazinylidene]ethanoate
C18H17N5O4
Acta Crystallographica Section E (2011) 67, 7 o1569
a=8.269(3)Å b=11.523(2)Å c=19.853(6)Å
α=87.44(2)° β=80.67(3)° γ=76.80(2)°